Spectrum Pharmaceuticals, Inc. (NASDAQ:SPPI)
A biopharmaceutical company that acquires and advances a diversified portfolio of drug candidates, with a focus on oncology, urology and other critical health challenges for which there are few other treatment options.
- Quote
- Commentary
- Scorecard
- Historical Prices
- Chart
- Stats
- Ratios
- Earnings/Growth Rates
- Statements
- SEC Filings
Recs
michaeltbryant
(< 20)
Submitted: 10/5/2009 1:17:21 AM :
Start Price:
$9.03
SPPI Score:
+17.87
Great brand. Pharma - defensive
Recs
Bhavtrader
(< 20)
Submitted: 9/26/2009 9:04:36 AM :
Start Price:
$6.55
SPPI Score:
+45.31
good pipeline, Coming FDA approval, no debt, 158 million in cash, possible buy-out
Recs
redwings103149
(59.17)
Submitted: 9/14/2009 11:14:02 AM :
Start Price:
$7.13
SPPI Score:
+30.74
85percent chance approval
Recs
Recs
Cencewolf
(< 20)
Submitted: 9/1/2009 3:31:57 AM :
Start Price:
$8.73
SPPI Score:
-1.70
good company (more importantly good catalyst's in the near future) featuring a major profit making possibility. this is a great long wager, but an even better mid term one.
Recs
Brian7992
(< 20)
Submitted: 8/20/2009 7:40:30 AM :
Start Price:
$6.29
SPPI Score:
+45.78
Best Bio Bets
Recs
fachini
(< 20)
Submitted: 7/30/2009 10:59:18 AM :
Start Price:
$6.72
SPPI Score:
+33.23
Appoval of 2 drugs
Recs
anshulinpc
(< 20)
Submitted: 6/26/2009 9:01:13 PM :
Start Price:
$7.00
SPPI Score:
+16.22
Employee Stock Purchase Plan Approved
Incentive Award Plan Approved
Recs
kevquinn
(< 20)
Submitted: 5/17/2009 9:20:04 PM :
Start Price:
$4.09
SPPI Score:
+125.28
Whether or not their next FDA decision on June 2nd is a thumbs-up or thumbs-down speculation will drive the price up (and a million dollar bet by 2 officers of the company doesn't hurt).
Recs
bigolelabtech
(68.69)
Submitted: 5/12/2009 8:06:39 AM :
Start Price:
$4.35
SPPI Score:
+112.26
One thing is for sure. I know absolutely nothing about this stock. Simply put, nada. All I know, is that it was green and it has a gain!! so I like!! I think it's splendid. The lady in my cubicle is talking in german and sounds a little.....different
Recs
projectchris
(40.13)
Submitted: 5/8/2009 10:08:41 AM :
Start Price:
$3.60
SPPI Score:
+166.63
Insider purchases of late. Many catalysts for short term. How many 100 million cap companies have 2 approved drugs in niche indications, with expanding labels in short term. Also have a drug in phase 3 with a drug that could possibly treat a large population. Also, possible partnering of Fusilev Asian rights on the horizon, to bring in even more cash for a company already loaded, and bringing down costs. My favorite is Zevalin though. A possible technology disruptor, that hasn't worked out well for the last 7 years(in regards to sales), but now is the time to shine. If they can get the reimbursement, so Hospitals don't lose money, watch out. Some of my fellow Nuclear Techs tell me, they couldn't provide this service due to losing too much money. I think Hospitals will rethink, once a better reimbursement becomes available. Sure there are risks in this one, but I think I will take a flier on this one.
Time to bring RIT to the forefront--Awesome technology that has been overlooked for too long
Recs
kcoyotee
(< 20)
Submitted: 7/2/2007 9:53:52 PM :
Start Price:
$7.47
SPPI Score:
+58.83
Upcoming FDA of Satraplatin and the almost %100 aprroval of it by Aug 15. Additonalyy another drug Oz in Phase 111 set to pass.
Recs
bnjguy8
(< 20)
Submitted: 6/25/2007 9:34:49 PM :
Start Price:
$6.71
SPPI Score:
+74.64
great company that makes generic cancer fighting drugs and has a really great future- this stock will probably go to 10 in the next six months ( its @ 6 and change now...)
Recs
albertvny
(66.54)
Submitted: 6/19/2007 3:07:09 PM :
Start Price:
$6.60
SPPI Score:
+78.98
have some very strong drugs in the pipeline - final phase! expect their prostate cancer drug to be on the market by end of 2007 or early 2008
Recs
terodean
(< 20)
Submitted: 4/20/2007 2:48:58 PM :
Start Price:
$7.15
SPPI Score:
+62.66
Ready to go in 3 months. Spivy tech approach to cancer therapy.
Recs
vizilite
(57.86)
Submitted: 3/9/2007 5:12:03 PM :
Start Price:
$5.85
SPPI Score:
+91.94
new categories
Recs
BoiseDad
(71.98)
Submitted: 1/12/2007 3:43:13 PM :
Start Price:
$5.66
SPPI Score:
+100.06
Is preparing to file with the FDA for very effective prostrate cancer drug, plus has two other drugs that it is submitting to the FDA. Risky, but looks good right now.
Recs
esebeus
(48.41)
Submitted: 12/28/2006 9:12:58 PM :
Start Price:
$5.45
SPPI Score:
+107.16
Promising drug pipeline with Satraplatin alone enough to justify current valuation. See spectrumpharma.com website for details on Phase 3 candidates to reach the mass market soon.
Recs
jim2mor7
(54.80)
Submitted: 11/10/2006 4:29:29 PM :
Start Price:
$5.65
SPPI Score:
+97.11
Small biotech company with several products in Phases I-III. The most promising compound, Satraplatin, is in phase III trials for prostate cancer. Spectrum has a partner in, GPC Biotech, which is paying for clinical trials. Spectrum will receive milestone and royalty payments.
Recs
MichaelCarrano
(77.28)
Submitted: 10/9/2006 3:54:54 PM :
Start Price:
$5.37
SPPI Score:
+104.97
Whole thing hinges on Satraplatin's FDA approval; it's been granted FDA fasttrack staus; my guess is it'll pass
RSS Headlines
Fool UK
- Show Me:
-
Outperform
-
Underperform
-
All
- Sort by:
-
Author
-
Recs
-
Date
-
Member Rating
-
Results 41 - 60 of 60 : « Previous 1 2 3